Search Results - "J. Clofent"

Refine Results
  1. 1

    Leukocytapheresis for steroid-dependent ulcerative colitis in clinical practice: results of a nationwide Spanish registry by Cabriada, J. L., Domènech, E., Ibargoyen, N., Hernández, V., Clofent, J., Ginard, D., Gutiérrez-Ibarluzea, I., Hinojosa, J.

    Published in Journal of gastroenterology (01-04-2012)
    “…Background Several small, prospective, open studies suggest that leukocytapheresis might be efficient in patients with steroid-dependent ulcerative colitis…”
    Get full text
    Journal Article
  2. 2

    Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer by Jover, R, Zapater, P, Castells, A, Llor, X, Andreu, M, Cubiella, J, Piñol, V, Xicola, R M, Bujanda, L, Reñé, J M, Clofent, J, Bessa, X, Morillas, J D, Nicolás-Pérez, D, Payá, A, Alenda, C

    Published in Gut (01-06-2006)
    “…Aim: Some retrospective studies have shown a lack of benefit of 5-fluorouracil (5-FU) adjuvant chemotherapy in patients with mismatch repair (MMR) deficient…”
    Get full text
    Journal Article
  3. 3

    Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers by Sánchez-Aragó, M, Formentini, L, Martínez-Reyes, I, García-Bermudez, J, Santacatterina, F, Sánchez-Cenizo, L, Willers, I M, Aldea, M, Nájera, L, Juarránz, Á, López, E C, Clofent, J, Navarro, C, Espinosa, E, Cuezva, J M

    Published in Oncogenesis (New York, NY) (01-04-2013)
    “…Recent findings in colon cancer cells indicate that inhibition of the mitochondrial H + -adenosine triphosphate (ATP) synthase by the ATPase inhibitory factor…”
    Get full text
    Journal Article
  4. 4

    Reverse phase protein microarrays quantify and validate the bioenergetic signature as biomarker in colorectal cancer by Aldea, M, Clofent, J, Núñez de Arenas, C, Chamorro, M, Velasco, M, Berrendero, J.R, Navarro, C, Cuezva, J.M

    Published in Cancer letters (08-12-2011)
    “…Highlights ► We report the quantity of proteins of energy metabolism in colon carcinomas. ► Colorectal carcinomas show a profound shift towards an enhanced…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    High incidence of large deletions in the PMS2 gene in Spanish Lynch syndrome families by Brea-Fernández, A.J., Cameselle-Teijeiro, J.M., Alenda, C., Fernández-Rozadilla, C., Cubiella, J., Clofent, J., Reñé, J.M., Anido, U., Milá, M., Balaguer, F., Castells, A., Castellvi-Bel, S., Jover, R., Carracedo, A., Ruiz-Ponte, C.

    Published in Clinical genetics (01-06-2014)
    “…Lynch syndrome (LS) is caused by germline mutations in one of the four mismatch repair (MMR) genes. Defects in this pathway lead to microsatellite instability…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    A comparative study of two histological techniques for the identification of cytomegalovirus infection in colorectal biopsies from patients with chronic inflammatory bowel disease by de Castro, M L, Tardío, A, del Campo, V, Estévez, A, Pineda, J R, Domínguez, F, Hermo, J A, Clofent, J

    “…the role that cytomegalovirus (CMV) plays in inflammatory bowel disease (IBD) is controversial. The diagnosis of CMV infection in IBD depends on viral…”
    Get full text
    Journal Article
  13. 13
  14. 14

    P773 Rescue treatment with tacrolimus in patients with severe inflammatory bowel disease (IBD) without response to intensification of biological therapy by Sanchis, L, Cortés, X, Clofent, J, Rodriguez, J, Molés, J R, Fernández, S, Borrás, J

    Published in Journal of Crohn's and colitis (16-01-2018)
    “…Abstract Background A significant percentage of patients with IBD do not respond to biological treatment. Tacrolimus (TAC) has shown utility in Crohn’s disease…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Crohn's Disease : A Review of Current Treatment with a Focus on Biologics by PANES, Julian, GOMOLLON, Fernando, TAXONERA, Carlos, HINOJOSA, Joaquin, CLOFENT, Juan, NOS, Pilar

    Published in Drugs (New York, N.Y.) (01-01-2007)
    “…Crohn's disease is a debilitating and expensive disease that is growing in incidence in both developing and developed countries. While conventional therapies,…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD) by Shivananda, S, Lennard-Jones, J, Logan, R, Fear, N, Price, A, Carpenter, L, van Blankenstein, M

    Published in Gut (01-11-1996)
    “…BACKGROUND: It has been suggested that the incidence of inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn's disease (CD), is…”
    Get full text
    Journal Article
  19. 19
  20. 20